APAC Collateral Ligament Stabilizer System Market

APAC Collateral Ligament Stabilizer Market Size (2024 to 2029)

The size of the Asia-Pacific Collateral Ligament Stabilizer Market is expected to increase from USD 30.77 Billion in 2024 to 47.17 Billion in 2029, at a CAGR of 8.92% owing to the increasing population of older people and elevated frequency of road accidents in countries like India and China. The high population of older people in developing countries like India and China provides huge prospects for growth in these places.

Ongoing research and development activities to manufacture innovative products by market key players are likely to add fuel to the market growth. Rising awareness in patients related to the advantages of utilizing a collateral ligament stabilizer system helps expand the development. Frequent increase of chronic diseases like osteoarthritis and growth in the number of trauma cases escalate market growth. 1 in 17 Australians suffers from sports trauma every year, according to a Sports Medicine Australia survey. Around 1/3rd of all injuries, disturbing children arise because of sports-related activities. According to The World Bank, the elder people population in Asia-Pacific is expected to grow quickly. Increase in expenses related to healthcare fuel the market growth.

The expensive nature of the products utilized acts as a significant barrier to collateral ligament stabilizer systems' growth during the forecast period. Also, the cost associated with knee replacement and knee arthritis is hindering the market growth.

This research report on the Asia Pacific Collateral Ligament Stabilizer Market has been segmented & sub-segmented into the following categories:

By Ligament Type

• Medial Collateral Ligament (MCL) 
• Lateral Collateral Ligament (LCL)   

By Injury Type

• Grade 1 Injury       
• Grade 2 Injury       
• Grade 3 Injury       

By End Use

• Hospitals  
• Orthopedic Clinics

By Country

• India
• China
• Japan
• South Korea
• Australia
• New Zealand
• Thailand
• Malaysia
• Vietnam
• Philippines
• Indonesia
• Singapore
• Rest of APAC

Regional Analysis

Asia-Pacific is anticipated to grow at a considerable pace and is expected to have a quick growth rate. Factors like a high increase in the aging population and expanding demand for collateral ligament stabilizer system in the region over the period. Rising sports injuries, road accidents, orthopedic diseases, and healthcare services are escalating the growth in the area. Intensifying demand for knee braces and support for pain management will influence the market. Ascending advanced technologies, together with the government's regular acceptable reimbursement policies, offer better opportunities in the CLSS market growth. 

Japan has the highest aging population; around 26.6% of Japan's people are 65 years and above accounted for 33.7 million people. China is leading the CLSS market with a dominant share in the region due to increasing research and development, several patients suffering from joint disorders and arthritis. India and Japan are witnessed to have rapid growth in the area due to factors like sports-related injuries like muscle sprains, ligament tears, and bone fractures. Investments made by the key players considering capable opportunities in the region are to propel the growth.

Some of the major manufacturers of the Asia Pacific CLSS market include DJO Global LLC, DePuy Synthes, Ossur, DeRoyal Industries, Bauerfeind, Seabourne Group, Arthrex, and Deroyal.